POST SUMMARY: As labor day approaches the biggest challenge for the pharma industry continues to be holding on to experienced and talented marketers who take the view that patient centered marketing is essential.
POST SUMMARY: There can be no doubt that changes are needed within biopharma DTC marketing to ensure that marketing to patients and consumers remains relevant. However, as long as antiquated hiring practices and rebels are denied entry into DTC marketing the industry is doomed to see budgets cut further as senior management looks to cut costs.
POST SUMMARY: To say that 2014 has been a challenging year for pharma would be an understatement. Budget cuts are kicking in and 86% of Rx’s are now generic medications while sales and marketing budgets have hit a dead end. More than that a lot of very talented and good DTC marketing people have left the industry because job satisfaction is a lot more important than a paycheck.
POST SUMMARY: A good agency can make you look good, but more importantly a good agency can develop a DTC digital strategy that both supports brand objectives and meets patient needs/wants. In an era where procurement can dictate which vendors you are allowed to do business with finding the right agency may be the most important challenge of any DTC marketer.
POST SUMMARY: “When [what you are deeply passionate about, what you can be best in the world at and what drives your economic engine] come together, not only does your work move toward greatness, but so does your life. For, in the end, it is impossible to have a great life unless it is a meaningful life. And it is very difficult to have a meaningful life without meaningful work. Perhaps, then, you might gain that rare tranquility that comes from knowing that you’ve had a hand in creating something of intrinsic excellence that makes a contribution. Indeed, you might even gain that deepest of all satisfactions: knowing that your short time here on this earth has been well spent, and that it mattered.” Jim Collins, Good to Great: Why Some Companies Make the Leap…and Others Don’t